These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 28199203)
41. [Neurochemical basis of ultra rapid opioid detoxication]. Golovko AI; Leont'eva LV; Golovko SI; Zefirov SIu; Konoplin DA; Romanenko OP Vopr Med Khim; 2002; 48(2):154-73. PubMed ID: 12189623 [TBL] [Abstract][Full Text] [Related]
42. A novel non-opioid protocol for medically supervised opioid withdrawal and transition to antagonist treatment. Rudolf G; Walsh J; Plawman A; Gianutsos P; Alto W; Mancl L; Rudolf V Am J Drug Alcohol Abuse; 2018; 44(3):302-309. PubMed ID: 28795846 [TBL] [Abstract][Full Text] [Related]
43. Neural mechanisms of drug reinforcement. Koob GF Ann N Y Acad Sci; 1992 Jun; 654():171-91. PubMed ID: 1632582 [TBL] [Abstract][Full Text] [Related]
44. Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions. Blum K; Bowirrat A; Braverman ER; Baron D; Cadet JL; Kazmi S; Elman I; Thanos PK; Badgaiyan RD; Downs WB; Bagchi D; Llanos-Gomez L; Gold MS Int J Environ Res Public Health; 2021 Nov; 18(21):. PubMed ID: 34770047 [TBL] [Abstract][Full Text] [Related]
46. Neurobiological mechanisms in cocaine and opiate dependence. Koob GF Res Publ Assoc Res Nerv Ment Dis; 1992; 70():79-92. PubMed ID: 1311123 [No Abstract] [Full Text] [Related]
48. Neuroadaptive mechanisms of addiction: studies on the extended amygdala. Koob GF Eur Neuropsychopharmacol; 2003 Dec; 13(6):442-52. PubMed ID: 14636960 [TBL] [Abstract][Full Text] [Related]
49. Perceived relapse risk and desire for medication assisted treatment among persons seeking inpatient opiate detoxification. Bailey GL; Herman DS; Stein MD J Subst Abuse Treat; 2013 Sep; 45(3):302-5. PubMed ID: 23786852 [TBL] [Abstract][Full Text] [Related]
50. Searching for evidence of genetic mediation of opioid withdrawal by opioid receptor gene polymorphisms. Jones JD; Luba RR; Vogelman JL; Comer SD Am J Addict; 2016 Jan; 25(1):41-8. PubMed ID: 26692286 [TBL] [Abstract][Full Text] [Related]
51. Dietary Supplementation with Omega-3 Polyunsaturated Fatty Acids Reduces Opioid-Seeking Behaviors and Alters the Gut Microbiome. Hakimian JK; Dong TS; Barahona JA; Lagishetty V; Tiwari S; Azani D; Barrera M; Lee S; Severino AL; Mittal N; Cahill CM; Jacobs JP; Walwyn WM Nutrients; 2019 Aug; 11(8):. PubMed ID: 31416242 [TBL] [Abstract][Full Text] [Related]
52. Role of oxytocin in the neuroadaptation to drugs of abuse. Sarnyai Z; Kovács GL Psychoneuroendocrinology; 1994; 19(1):85-117. PubMed ID: 9210215 [TBL] [Abstract][Full Text] [Related]
53. Pro-Dopamine Regulator - (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome (RDS). Blum K; Febo M; Fried L; Baron D; Braverman ER; Dushaj K; Li M; Demetrovics Z; Badgaiyan RD J Reward Defic Syndr Addict Sci; 2017; 3(1):3-13. PubMed ID: 28804788 [TBL] [Abstract][Full Text] [Related]
54. An anatomical basis for opponent process mechanisms of opiate withdrawal. Radke AK; Rothwell PE; Gewirtz JC J Neurosci; 2011 May; 31(20):7533-9. PubMed ID: 21593338 [TBL] [Abstract][Full Text] [Related]
55. Social Influences in Animal Models of Opiate Addiction. Tomek SE; Olive MF Int Rev Neurobiol; 2018; 140():81-107. PubMed ID: 30193710 [TBL] [Abstract][Full Text] [Related]
57. Inflated reward value in early opiate withdrawal. Wassum KM; Greenfield VY; Linker KE; Maidment NT; Ostlund SB Addict Biol; 2016 Mar; 21(2):221-33. PubMed ID: 25081350 [TBL] [Abstract][Full Text] [Related]
58. Motivational state determines the functional role of the mesolimbic dopamine system in the mediation of opiate reward processes. Laviolette SR; Nader K; van der Kooy D Behav Brain Res; 2002 Feb; 129(1-2):17-29. PubMed ID: 11809491 [TBL] [Abstract][Full Text] [Related]
59. [Neurological deficiency symptoms in opiate dependence during the abstinence phase]. Benos J; Gatsonis A Med Welt; 1980 Jul; 31(27):1038-9. PubMed ID: 7421540 [No Abstract] [Full Text] [Related]
60. Opiate state controls bi-directional reward signaling via GABAA receptors in the ventral tegmental area. Laviolette SR; Gallegos RA; Henriksen SJ; van der Kooy D Nat Neurosci; 2004 Feb; 7(2):160-9. PubMed ID: 14730310 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]